Plant Comparison

Bay-leaf willowherb vs Meadowsweet

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant
Second plant
Show:
Plant ABay-leaf willowherbEpilobium parviflorumOnagraceaeFull monograph →
Plant BMeadowsweetFilipendula ulmariaRosaceaeFull monograph →

At a glance

Bay-leaf willowherb and Meadowsweet: they share 8 indicated uses (arthritis / joint pain, cancer (anticancer research), infection (general), …); 4 pharmacological actions in common.

Bay-leaf willowherbMeadowsweet
Constituents33
Pharmacological actions48
Indicated uses916
Safety notes22
Cited sources1517
Indicated uses
Only Bay-leaf willowherb
Prostate support
Shared (8)
Arthritis / joint painCancer (anticancer research)Infection (general)Inflammation (general)Skin irritationUrinary supportUrinary tract infection (UTI)Wounds
Only Meadowsweet
Acid refluxBack painHeadacheIndigestionMenstrual crampsMuscle spasmPain (general)Swelling / fluid retention
Pharmacological actions
Only Bay-leaf willowherb
none
Shared (4)
Anti-inflammatoryAnticancer (preclinical)AntimicrobialAntioxidant
Only Meadowsweet
Analgesic (pain relief)AntispasmodicDiureticGastroprotective

Evidence face-off — shared uses

ConditionBay-leaf willowherbMeadowsweetVerdict
Arthritis / joint pain1/101/10Comparable evidence
Cancer (anticancer research)2/102/10Comparable evidence
Infection (general)1/101/10Comparable evidence
Inflammation (general)1/101/10Comparable evidence
Skin irritation1/101/10Comparable evidence
Urinary support5/101/10Stronger for Bay-leaf willowherb
Urinary tract infection (UTI)5/101/10Stronger for Bay-leaf willowherb
Wounds1/101/10Comparable evidence

Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.

Key Constituents

Macrocyclic ellagitannins (notably oenothein B)[4, 5, 6, 7, 8, 13]

Characteristic Epilobium polyphenols underlying the anti-inflammatory and prostate activity; a genus review identifies oenothein B as the dominant constituent and likely driver of the antimicrobial, anti-inflammatory, anti-proliferative and antioxidant effects.

TanninsPhenolic compounds
Flavonoids (myricetin and quercetin glycosides)[11, 13]

Antioxidant constituents.

FlavonoidsGlycosidesQuercetin
Plant sterols (beta-sitosterol)[13]

Sterols associated with benign prostatic hyperplasia support.

Phytosterols
Salicylates (methyl salicylate, salicylic acid derivatives)[1, 4]

Historically the source of aspirin's chemical inspiration; provide the plant's analgesic and anti-inflammatory activity, buffered by co-occurring mucilage and tannins.

Flavonoids (quercetin, rutin, hyperoside)[1]

Antioxidant constituents contributing to the plant's anti-inflammatory and gastroprotective effects.

FlavonoidsQuercetinRutin
Tannins and essential oil[1]

Contribute to astringency and the characteristic sweet almond-like fragrance.

TanninsEssential (volatile) oil

Pharmacological Actions

Anti-inflammatory[1, 3, 4, 6, 10, 13]

Anti-inflammatory (inhibits COX-1 and COX-2 prostaglandin synthesis)

Anticancer (preclinical)[3]
Antimicrobial[13]

Antibacterial, including against Escherichia coli (urinary support)

Antioxidant[1, 6, 9, 10, 11, 13]

Antioxidant (hydroxyl-radical scavenging)

Analgesic (pain relief)[5, 14, 15, 16]
Anti-inflammatory[1, 3, 4, 5, 14, 15, 16]
Anticancer (preclinical)[2, 12]
Antimicrobial[14, 15, 16]
Antioxidant[1, 6, 7, 14, 15, 16]
Antispasmodic[14, 15, 16]

Antispasmodic (cramp easing)

Diuretic[9, 11, 14, 15, 16]
Gastroprotective[1, 14, 15, 16]

Traditional & Indicated Uses

Arthritis / joint pain[13]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Cancer (anticancer research)[3]Traditional · 2/10

inferred from anticancer action

Evidence: 2
Label: Cancer (anticancer research)
Infection (general)[13]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Infection (general)
Inflammation (general)[13]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Inflammation (general)
Prostate support[4, 13, 15]Moderate · 5/10

Supports lower urinary tract symptoms of benign prostatic hyperplasia (prostate support) - a genus Epilobium review notes traditional BPH use attributed mainly to oenothein B, though clinical evidence is not yet conclusive

Evidence: 5
Label: Prostate support
Skin irritation[13]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Skin irritation
Urinary support[4, 13, 15]Moderate · 5/10

Antibacterial, including against Escherichia coli (urinary support); Supports lower urinary tract symptoms of benign prostatic hyperplasia (prostate support) - a genus Epilobium review notes traditional BPH use attributed mainly to oenothein B, though clinical evidence is not yet conclusive

Evidence: 5
Label: Urinary support
Urinary tract infection (UTI)[4, 13, 15]Moderate · 5/10

Supports lower urinary tract symptoms of benign prostatic hyperplasia (prostate support) - a genus Epilobium review notes traditional BPH use attributed mainly to oenothein B, though clinical evidence is not yet conclusive

Evidence: 5
Label: Urinary tract infection (UTI)
Wounds[13]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Wounds
Acid reflux[14, 15, 16]Traditional · 1/10

inferred from gastroprotective action

Evidence: 1
Label: Acid reflux
Arthritis / joint pain[14, 15, 16]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Back pain[14, 15, 16]Traditional · 1/10

inferred from analgesic action

Evidence: 1
Label: Back pain
Cancer (anticancer research)[2, 12]Traditional · 2/10

inferred from anticancer action

Evidence: 2
Label: Cancer (anticancer research)
Headache[14, 15, 16]Traditional · 1/10

inferred from analgesic action

Evidence: 1
Label: Headache
Indigestion[14, 15, 16]Traditional · 1/10

inferred from gastroprotective action

Evidence: 1
Label: Indigestion
Infection (general)[14, 15, 16]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Infection (general)
Inflammation (general)[14, 15, 16]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Inflammation (general)
Menstrual cramps[14, 15, 16]Traditional · 1/10

inferred from antispasmodic action

Evidence: 1
Label: Menstrual cramps
Muscle spasm[14, 15, 16]Traditional · 1/10

inferred from antispasmodic action

Evidence: 1
Label: Muscle spasm
Pain (general)[14, 15, 16]Traditional · 1/10
Evidence: 1
Label: Pain (general)
Skin irritation[14, 15, 16]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Skin irritation
Swelling / fluid retention[14, 15, 16]Traditional · 1/10

inferred from diuretic action

Evidence: 1
Label: Swelling / fluid retention
Urinary support[14, 15, 16]Traditional · 1/10

inferred from diuretic action

Evidence: 1
Label: Urinary support
Urinary tract infection (UTI)[14, 15, 16]Traditional · 1/10

inferred from diuretic action

Evidence: 1
Label: Urinary tract infection (UTI)
Wounds[14, 15, 16]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Wounds

Safety, Cautions & Contraindications

Safety note[15]Info

Lower urinary tract / prostate symptoms must be medically assessed first to exclude prostate cancer; willowherb is a supportive measure, not a substitute for diagnosis and treatment.

Safety note[15]Info

Well tolerated over three months in clinical use; longer-term safety data are limited.

Safety note[14, 15, 16]Caution

Generally safe in normal culinary and medicinal doses. Avoid in salicylate sensitivity or aspirin allergy. Not recommended for children with viral illnesses (Reye's syndrome risk, as with other salicylate-containing plants). Avoid during pregnancy and breastfeeding.

Safety note[14, 15, 16, 17]Caution

Duke (2002) rates meadowsweet as ++ and notes analgesic, antiulcer, antirheumatic, astringent, and anti-aggregant activities at the experimental level (score 1). The plant is historically significant as a precursor to aspirin — salicylate compounds in meadowsweet were originally used to derive acetylsalicylic acid. Unlike aspirin, meadowsweet's salicylates are combined with protective mucilaginous compounds that may reduce gastric irritation. Duke notes that individuals with aspirin (salicylate) sensitivity should avoid meadowsweet; the plant also has anticoagulant properties that may interact with blood-thinning medications (Duke, 2002).

External Ids

Gbif: 3189157
Wikidata: Q159094
Gbif: 2987999
Wikidata: Q147176

Botanical Description

Slender, softly hairy perennial herb with narrow, lance-shaped leaves and small, four-petalled, pale pink to lilac flowers with a notched tip, borne singly in the upper leaf axils. After flowering, long, narrow seed pods split to release cottony-tufted seeds, typical of the willowherb genus.[13]

Height: 20-60 cm
Habit: Slender, softly hairy, erect perennial herb
Leaves: Narrow, lance-shaped, softly hairy
Flowers: Small, four-petalled, pale pink to lilac, notched, borne singly in upper leaf axils
Stem: Slender, softly hairy, erect
Root: Fibrous root with short rhizome
Fruit: Long, narrow seed pod releasing cottony-tufted seeds
Flowering Period: June-September

Tall, moisture-loving perennial herb with pinnately compound leaves, dark green above and whitish-downy beneath, the leaflets sharply toothed. Dense, fluffy, creamy-white flower clusters with a strong, sweet, almond-like fragrance are borne atop reddish, grooved stems.[1]

Height: 60-120 cm
Habit: Tall, erect, moisture-loving perennial herb
Leaves: Pinnately compound, dark green above, whitish-downy beneath, sharply toothed leaflets
Flowers: Dense, fluffy, creamy-white clusters with a strong sweet almond-like fragrance
Stem: Reddish, grooved, erect
Root: Fibrous roots from a short rhizome
Fruit: Small, spirally twisted achenes
Flowering Period: June-September

Habitat

Grows in damp meadows, ditches, streamsides and waste ground on moist soils; native to Europe and temperate Asia.[13]

Grows in damp meadows, marshes, riverbanks, ditches and wet woodland margins; native to Europe and temperate Asia, favouring moist, nutrient-rich ground.[1]

Harvesting

The flowering aerial parts are cut in summer while in flower, and dried in a warm, shaded, airy place.[13]

Parts: Aerial parts (herb)
Season: Summer flowering period

The flowering tops, leaf and stem are cut in summer as the flowers open, when the characteristic salicylate content is highest, and dried in a warm, shaded, airy place.[1]

Parts: Flower, Leaf, Stem
Season: Summer, at flowering

Traditional Uses

Small-flowered willowherb, along with related Epilobium species, has a Central European folk tradition as a supportive remedy for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH) and prostatitis, and as an antimicrobial and anti-inflammatory herb for minor infections; the traditional prostate-support use is attributed mainly to its oenothein B content, though robust clinical evidence remains limited.[13]

Meadowsweet is historically significant as the plant from which salicylic acid derivatives (the chemical basis of aspirin) were first isolated, and has long been used in European folk medicine as an anti-inflammatory, analgesic and gastroprotective remedy for feverish colds, rheumatic and joint pain, and digestive complaints such as acid reflux and indigestion - notably, its natural mucilage is thought to buffer the gastric irritation associated with isolated salicylates.[1, 4]

Preparations

Infusion[13]

Dried flowering herb infused in hot water as a traditional urinary and prostate-support tea.

Infusion[1]

Dried flower, leaf and stem infused in hot water as a traditional anti-inflammatory and digestive tea.

Tincture[13]

Tincture (1:5) of the dried aerial parts; single dose 2-4 ml, daily dose 6-12 ml per the EU herbal monograph. Educational reference only, not a prescription.

Standardised extract[4]

Concentrated extract studied in vitro and in vivo for anti-inflammatory and gastroprotective activity.

Dosage

Infusion[14]

The EU herbal monograph gives 1.5-2.0 g of the comminuted herb in 250 mL of boiling water as an infusion, twice daily, in adults and elderly; long-term use is possible. Lower urinary tract or prostate symptoms should always be medically assessed first, and the monograph directs that a doctor be consulted if fever, spasms, blood in the urine, painful urination or urinary retention occur. Educational reference only, not a prescription.

Infusion[13]

The EU herbal monograph gives a single dose of 1.5-6 g of the comminuted herb as an infusion, for a daily dose of 2-18 g, in adults and elderly; a powdered herbal substance at 250-500 mg per dose (250-1500 mg daily) and a 1:5 tincture at 2-4 mL per dose (6-12 mL daily) are also listed. Contraindicated in hypersensitivity to salicylates. For rheumatic-type complaints, not to be used for more than 4 weeks. Not recommended under 18 years. Educational reference only, not a prescription.

References

REF-0803, REF-0804, REF-0805, REF-0618, REF-2297, REF-2298, REF-2299, REF-2300, REF-2301, REF-2302, REF-2303, REF-2304
REF-0815, REF-0816, REF-0817, REF-2030, REF-2031, REF-2032, REF-2033, REF-2034, REF-2035, REF-2036, REF-2037, REF-2038

Lookalikes Review

Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07

References & Sources

  1. Vitalone, A. and Allkanjari, O (2018) 'Epilobium spp: Pharmacology and Phytochemistry', Phytotherapy Research, 32(7), pp. 1229-1240. doi:10.1002/ptr.6072 Traditional / reference
    https://doi.org/10.1002/ptr.6072
  2. Cicero, A.F.G., Allkanjari, O., Busetto, G.M., Cai, T. et al (2019) 'Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer', Archivio Italiano di Urologia e Andrologia, 91(3), pp. 139-152. doi:10.4081/aiua.2019.3.139 Traditional / reference
    https://doi.org/10.4081/aiua.2019.3.139
  3. Vlase, A.M., Toiu, A., Gligor, O., Muntean, D. et al (2024) 'Investigation of Epilobium hirsutum L. Optimized Extract's Anti-Inflammatory and Antitumor Potential', Plants (Basel), 13(2), pp. 198. doi:10.3390/plants13020198 Preclinical
    https://doi.org/10.3390/plants13020198
  4. Granica, S., Piwowarski, J.P., Czerwinska, M.E. and Kiss, A.K (2014) 'Phytochemistry, pharmacology and traditional uses of different Epilobium species (Onagraceae): a review', Journal of Ethnopharmacology, pp. 316--346. doi:10.1016/j.jep.2014.08.036 Traditional / reference
    https://doi.org/10.1016/j.jep.2014.08.036
  5. Ramstead, A.G., Schepetkin, I.A., Quinn, M.T. and Jutila, M.A (2012) 'Oenothein B, a cyclic dimeric ellagitannin isolated from Epilobium angustifolium, enhances IFN-gamma production by lymphocytes', PLoS One, 7(11), pp. e50546. doi:10.1371/journal.pone.0050546 Preclinical
    https://doi.org/10.1371/journal.pone.0050546
  6. Kiss, A.K., Bazylko, A., Filipek, A., Granica, S., Jaszewska, E., Kiarszys, U., Kosmider, A. and Piwowarski, J (2011) 'Oenothein B's contribution to the anti-inflammatory and antioxidant activity of Epilobium sp', Phytomedicine, 18(7), pp. 557-560. doi:10.1016/j.phymed.2010.10.016 Preclinical
    https://doi.org/10.1016/j.phymed.2010.10.016
  7. Schepetkin, I.A., Kirpotina, L.N., Jakiw, L., Khlebnikov, A.I., Blaskovich, C.L., Jutila, M.A. and Quinn, M.T (2009) 'Immunomodulatory activity of oenothein B isolated from Epilobium angustifolium', Journal of Immunology, 183(10), pp. 6754-6766. doi:10.4049/jimmunol.0901827 Preclinical
    https://doi.org/10.4049/jimmunol.0901827
  8. Ducrey, B., Marston, A., Gohring, S., Hartmann, R.W. and Hostettmann, K (1997) 'Inhibition of 5-alpha-reductase and aromatase by the ellagitannins oenothein A and oenothein B from Epilobium species', Planta Medica, 63(2), pp. 111-114. doi:10.1055/s-2006-957624 Preclinical
    https://doi.org/10.1055/s-2006-957624
  9. Schepetkin, I.A., Ramstead, A.G., Kirpotina, L.N., Voyich, J.M., Jutila, M.A. and Quinn, M.T (2016) 'Therapeutic potential of polyphenols from Epilobium angustifolium (fireweed)', Phytotherapy Research, 30(8), pp. 1287-1297. doi:10.1002/ptr.5648 Meta-analysis / review
    https://doi.org/10.1002/ptr.5648
  10. Merighi, S., Travagli, A., Tedeschi, P., Marchetti, N. and Gessi, S (2021) 'Antioxidant and anti-inflammatory effects of Epilobium parviflorum, Melilotus officinalis and Cardiospermum halicacabum plant extracts in macrophage and microglial cells', Cells, 10(10), pp. 2691. doi:10.3390/cells10102691 Preclinical
    https://doi.org/10.3390/cells10102691
  11. Hevesi Toth, B., Blazics, B. and Kery, A (2009) 'Polyphenol composition and antioxidant capacity of Epilobium species', Journal of Pharmaceutical and Biomedical Analysis, 49(1), pp. 26-31. doi:10.1016/j.jpba.2008.09.047 Preclinical
    https://doi.org/10.1016/j.jpba.2008.09.047
  12. Vitalone, A., McColl, J., Thome, D., Costa, L.G. and Tita, B (2003) 'Characterization of the effect of Epilobium extracts on human cell proliferation', Pharmacology, 69(2), pp. 79-87. doi:10.1159/000072360 Preclinical
    https://doi.org/10.1159/000072360
  13. Steenkamp, V., Gouws, M.C., Gulumian, M., Elgorashi, E.E. and van Staden, J (2005) 'Studies on antibacterial, anti-inflammatory and antioxidant activity of herbal remedies used in the treatment of benign prostatic hyperplasia and prostatitis', Journal of Ethnopharmacology, pp. 2005. doi:10.1016/j.jep.2005.07.007 Traditional / reference
    https://doi.org/10.1016/j.jep.2005.07.007
  14. European Medicines Agency (HMPC) (2015) 'European Union herbal monograph on Epilobium angustifolium L. and/or Epilobium parviflorum Schreb., herba'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-epilobium-angustifolium-l-andor-epilobium-parviflorum-schreb-herba_en.pdf Traditional / reference
    https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-epilobium-angustifolium-l-andor-epilobium-parviflorum-schreb-herba_en.pdf
  15. Coulson, S., Rao, A., Beck, S.L., Steels, E., Gramotnev, H. and Vitetta, L (2013) 'A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation (containing Epilobium parviflorum) for the management of symptoms of benign prostatic hypertrophy', Complementary Therapies in Medicine. doi:10.1016/j.ctim.2013.01.007 Randomized trial
    https://doi.org/10.1016/j.ctim.2013.01.007
  1. Samardžić, S., Arsenijević, J., Božić, D., Milenković, M. et al (2017) 'Antioxidant, anti-inflammatory and gastroprotective activity of Filipendula ulmaria (L.) Maxim. and Filipendula vulgaris Moench', Journal of Ethnopharmacology, 213, pp. 132-137. doi:10.1016/j.jep.2017.11.013 Preclinical
    https://doi.org/10.1016/j.jep.2017.11.013
  2. Andonova, T., Muhovski, Y., Apostolova, E., Naimov, S. et al (2024) 'DNA-Protective, Antioxidant and Anti-Carcinogenic Potential of Meadowsweet (Filipendula ulmaria) Dry Tincture', Antioxidants (Basel), 13(10), pp. 1200. doi:10.3390/antiox13101200 Preclinical
    https://doi.org/10.3390/antiox13101200
  3. Van der Auwera, A., Peeters, L., Foubert, K., Piazza, S. et al (2023) 'In Vitro Biotransformation and Anti-Inflammatory Activity of Constituents and Metabolites of Filipendula ulmaria', Pharmaceutics, 15(4), pp. 1291. doi:10.3390/pharmaceutics15041291 Preclinical
    https://doi.org/10.3390/pharmaceutics15041291
  4. Katanic, J., Boroja, T., Mihailovic, V., Nikles, S., Pan, S., Rosic, G., Selakovic, D., Joksimovic, J., Mitrovic, S. and Bauer, R (2016) 'In vitro and in vivo assessment of meadowsweet (Filipendula ulmaria) as anti-inflammatory agent', Journal of Ethnopharmacology, 193, pp. 627-636. doi:10.1016/j.jep.2016.10.015 Preclinical
    https://doi.org/10.1016/j.jep.2016.10.015
  5. Samardzic, S., Tomic, M., Pecikoza, U., Stepanovic-Petrovic, R. and Maksimovic, Z (2016) 'Antihyperalgesic activity of Filipendula ulmaria (L.) Maxim. and Filipendula vulgaris Moench in a rat model of inflammation', Journal of Ethnopharmacology, 193, pp. 652-656. doi:10.1016/j.jep.2016.10.024 Preclinical
    https://doi.org/10.1016/j.jep.2016.10.024
  6. Katanic, J., Matic, S., Pferschy-Wenzig, E., Kretschmer, N., Boroja, T., Mihailovic, V., Stankovic, V., Stankovic, N., Mladenovic, M., Stanic, S., Mihailovic, M. and Bauer, R (2016) 'Filipendula ulmaria extracts attenuate cisplatin-induced liver and kidney oxidative stress in rats: In vivo investigation and LC-MS analysis', Food and Chemical Toxicology, 99, pp. 86-102. doi:10.1016/j.fct.2016.11.018 Preclinical
    https://doi.org/10.1016/j.fct.2016.11.018
  7. Arsenijevic, N., Selakovic, D., Katanic Stankovic, J.S., Mihailovic, V., Mitrovic, S., Milenkovic, J., Milanovic, P., Vasovic, M., Nikezic, A., Milosevic-Djordjevic, O., Zivanovic, M., Filipovic, N., Jakovljevic, V., Jovicic, N. and Rosic, G (2021) 'Variable neuroprotective role of Filipendula ulmaria extract in rat hippocampus', Journal of Integrative Neuroscience, 20(4), pp. 871-883. doi:10.31083/j.jin2004089 Preclinical
    https://doi.org/10.31083/j.jin2004089
  8. Matic, S., Katanic, J., Stanic, S., Mladenovic, M., Stankovic, N., Mihailovic, V. and Boroja, T (2015) 'In vitro and in vivo assessment of the genotoxicity and antigenotoxicity of the Filipendula hexapetala and Filipendula ulmaria methanol extracts', Journal of Ethnopharmacology, 174, pp. 287-292. doi:10.1016/j.jep.2015.08.025 Preclinical
    https://doi.org/10.1016/j.jep.2015.08.025
  9. Pannakal, S.T., Eilstein, J., Hubert, J., Kotland, A., Prasad, A., Gueguiniat-Prevot, A., Juchaux, F., Beaumard, F., Seru, G., John, S. and Roy, D (2023) 'Rapid Chemical Profiling of Filipendula ulmaria Using CPC Fractionation, 2-D Mapping of 13C NMR Data, and High-Resolution LC-MS', Molecules, 28(17), pp. 6349. doi:10.3390/molecules28176349 Preclinical
    https://doi.org/10.3390/molecules28176349
  10. Valle, M.G., Nano, G.M. and Tira, S (1988) 'The Essential Oil of Filipendula ulmaria', Planta Medica, 54(2), pp. 181-182. doi:10.1055/s-2006-962390 Preclinical
    https://doi.org/10.1055/s-2006-962390
  11. Popowski, D., Zentek, J., Piwowarski, J.P. and Granica, S (2021) 'Gut Microbiota of Pigs Metabolizes Extracts of Filipendula ulmaria and Orthosiphon aristatus - Herbal Remedies Used in Urinary Tract Disorders', Planta Medica, 88(3-04), pp. 254-261. doi:10.1055/a-1647-2866 Preclinical
    https://doi.org/10.1055/a-1647-2866
  12. Bespalov, V.G., Alexandrov, V.A., Semenov, A.L., Kovan'ko, E.G., Ivanov, S.D., Vysochina, G.I., Kostikova, V.A. and Baranenko, D.A (2016) 'The inhibitory effect of meadowsweet (Filipendula ulmaria) on radiation-induced carcinogenesis in rats', International Journal of Radiation Biology, 93(4), pp. 394-401. doi:10.1080/09553002.2016.1257834 Preclinical
    https://doi.org/10.1080/09553002.2016.1257834
  13. European Medicines Agency (HMPC) (2011) 'Community herbal monograph on Filipendula ulmaria (L.) Maxim., herba'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-filipendula-ulmaria-l-maxim-herba-first-version_en.pdf Traditional / reference
    https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-filipendula-ulmaria-l-maxim-herba-first-version_en.pdf
  14. Bridge, J (2008) 'The Herbal Remedy Handbook'. Traditional / reference
    https://scholar.google.com/scholar?q=The%20Herbal%20Remedy%20Handbook
  15. Drummond, E.M., Harbourne, N., Marete, E., Jacquier, J.C., O'Riordan, D. and Gibney, E.R (2013) 'Inhibition of pro-inflammatory biomarkers in THP1 macrophages by polyphenols derived from chamomile, meadowsweet and willow bark', 27(4), pp. 588--594. Traditional / reference
    https://scholar.google.com/scholar?q=Inhibition%20of%20pro-inflammatory%20biomarkers%20in%20THP1%20macrophages%20by%20polyphenols%20derived%20from%20chamomile%2C%20meadowsweet%20and%20willow%20bark
  16. Grieve, M (1931) 'A Modern Herbal'. Traditional / reference
    https://scholar.google.com/scholar?q=A%20Modern%20Herbal
  17. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.